Outcomes of interventional electrophysiology in children under 2 years of age

Christian J Turner1, Kai C Lau, Gary F Sholler

  • 1The Heart Centre for Children, The Children's Hospital at Westmead, Sydney, Australia. christian.j.turner@gmail.com

Cardiology in the Young
|December 21, 2011
PubMed

Insights

Interventional electrophysiology is a safe and effective treatment for infants under 2 years old with difficult-to-treat arrhythmias. This procedure offers a viable therapeutic option when other medical management fails.

Area of Science:

  • Pediatric Cardiology
  • Cardiac Electrophysiology

Background:

  • Limited data exist on interventional electrophysiology safety and efficacy in children under 2 years old.
  • Arrhythmias in young children pose significant clinical challenges.

Purpose of the Study:

  • To evaluate the efficacy and safety of interventional electrophysiology in infants under 2 years.
  • To identify indications, procedural outcomes, and complication rates in this pediatric population.

Main Methods:

  • Retrospective review of 23 procedures in 17 infants under 2 years (1995-2009).
  • Analysis of indications, procedural details, short- and long-term success, and complications.
  • Included patients with and without congenital heart disease.

Main Results:

  • Most common indications: drug-resistant arrhythmia (59%) and hemodynamically unstable arrhythmia (41%).
  • 88% long-term success rate (15/17 patients) after initial and repeat procedures.
  • One non-procedural death and three minor complications; cryotherapy was successfully used in one case.

Conclusions:

  • Interventional electrophysiology is a viable therapeutic option for infants under 2 years with refractory arrhythmias.
  • The procedure demonstrates favorable safety and efficacy in this young patient group.
Abstract

Related Concept Videos

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...